AdaptHealth Corp. (NASDAQ:AHCO) The stock position was raised by Quest Partners LLC

Quest Partners LLC raised its position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 11,522.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,228 shares of the company’s stock after acquiring an additional 10,140 shares during the quarter. Quest Partners LLC’s holdings in AdaptHealth were worth $102,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in AdaptHealth by 8.9% in the first quarter. Vanguard Group Inc. now owns 10,017,722 shares of the company’s stock worth $115,304,000 after purchasing an additional 818,241 shares during the period. Reinhart Partners LLC. boosted its holdings in shares of AdaptHealth by 1.4% in the second quarter. Reinhart Partners LLC. now owns 4,269,303 shares of the company’s stock valued at $42,693,000 after buying an additional 59,092 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of AdaptHealth by 21.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,040,947 shares of the company’s stock valued at $7,589,000 after buying an additional 183,135 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of AdaptHealth by 2.8% in the second quarter. Bank of New York Mellon Corp now owns 746,211 shares of the company’s stock worth $7,462,000 after purchasing an additional 20,599 shares during the period. Finally, First Eagle Investment Management LLC boosted its stake in AdaptHealth by 18.2% in the first quarter. First Eagle Investment Management LLC now owns 594,951 shares of the company’s stock valued at $6,848,000 after buying an additional 91,772 shares in the last quarter. 82.67% of shares are currently owned by institutional investors.

AdaptHealth stock up 4.8%

Shares of AdaptHealth stock opened at $11.43 on Tuesday. AdaptHealth Corp. has a 1 year low of $6.37 and a 1 year high of $11.90. The company has a market cap of $1.52 billion, a P/E ratio of -2.17, a PEG ratio of 1.75 and a beta of 1.10. The company’s fifty day moving average price is $10.66 and its two hundred day moving average price is $10.42. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.15, and a quick ratio of 0.94.

AdaptHealth (NASDAQ:AHCO – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). The company had revenue of $805.98 million during the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a positive return on equity of 9.58% and a negative net margin of 21.20%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.16 EPS. As a group, research analysts forecast that AdaptHealth Corp. it will post 0.87 EPS for the current year.

Indoor activity

In related news, Director David Solomon Williams III sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the sale, the director now owns 36,899 shares of the company’s stock, valued at $415,482.74. The sale was disclosed in a filing with the SEC, which is available on the SEC’s website. Insiders own 4.43% of the company’s shares.

Analysts set new price targets

Separately, Royal Bank of Canada reiterated an “outperform” rating and issued a $13.00 price objective on shares of AdaptHealth in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat , AdaptHealth currently has an average rating of “Hold” and a consensus price target of $10.70.

Read the latest stock analysis on AdaptHealth

AdaptHealth Company Profile

(Free report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies and home and related services in the United States. The company provides sleep therapy equipment, supplies and related services such as CPAP and bi-PAP services to people with obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME for patients discharged from acute care and other facilities; oxygen services and related chronic home therapy; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Further reading

Want to see what other hedge funds AHCO owns? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for AdaptHealth Corp. (NASDAQ:AHCO – Free Report).

Get news and reviews for AdaptHealth Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AdaptHealth and related companies with MarketBeat.com’s FREE daily email newsletter.